Pi Research
California, USA, SA 9000
Europe minimal residual disease (MRD) testing market was valued at $ 265.6 million in 2021.
Europe minimal residual disease this comprehensive study of MRD testing patterns shows
consistent practice across France, Germany, Italy, Spain, and the UK with respect to the
timing and frequency of MRD testing, Europe minimal residual disease aligning with use of
national protocols. premium primary and secondary information sources with inputs derived from
industry professionals across the value chain.
5 out of 5 from 1 reviews